RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis

PURPOSE: The mode of action of targeted cancer agents (TCAs) differs from classic chemotherapy, which leads to concerns about the role of RECIST in evaluating tumor response in trials with TCAs. We investigated the performance of RECIST using a pooled database from 50 clinical trials with at least o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Litière, Saskia, Isaac, Gaëlle, De Vries, Elisabeth G.E., Bogaerts, Jan, Chen, Alice, Dancey, Janet, Ford, Robert, Gwyther, Stephen, Hoekstra, Otto, Huang, Erich, Lin, Nancy, Liu, Yan, Mandrekar, Sumithra, Schwartz, Lawrence H., Shankar, Lalitha, Therasse, Patrick, Seymour, Lesley
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2019
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494357/
https://ncbi.nlm.nih.gov/pubmed/30860949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.01100
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars